Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

The left atrial substrate plays a significant role in the development of complex atrial tachycardia in patients with precapillary pulmonary hypertension

Z. Fingrova, S. Havranek, D. Ambroz, P. Jansa, A. Linhart,

. 2019 ; 19 (1) : 157. [pub] 20190628

Language English Country Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

BACKGROUND: Atrial fibrillation (AF) and related atrial tachyarrhythmias (AT), including type I atrial flutter (AFL) are frequently observed in patients with pulmonary hypertension (PH). Their relationship to hemodynamic changes, atrial size, and ventricular function are still not fully verified. METHODS: We retrospectively studied hemodynamic data, echocardiographic findings and arrhythmia incidence in 814 patients with invasively diagnosed precapillary PH (aged 59 ± 14 years; 46% males). Patients with combined or post-capillary PH were excluded. RESULTS: AF / AT were identified in 225 (28%) of all the study population. Compared to the subgroup without arrhythmia, patients with AF / AT had elevated right atrial pressure (11 ± 5 vs. 9 ± 5 mmHg), wedge pressure (11 ± 3 vs. 10 ± 3), a more enlarged right atrium (50 ± 12 vs. 47 ± 11 mm) and an increased left atrial diameter in the parasternal long axis projection, p <  0.05 for all comparisons. In the multivariate model, the left atrial size, patient age, arterial hypertension, diabetes and type of PH were associated with AF / AT occurrence, p <  0.05. Patients with type I AFL were more frequently male (39 (80%) vs. 62 (42%)), were younger (61 ± 11 vs. 67 ± 10 years), had increased pulmonary artery mean pressure (50 ± 12 vs. 45 ± 12 mmHg), less advanced left atrial dilatation (38 ± 10 vs. 42 ± 7 mm), and a more enlarged right atrium (56 ± 12 vs. 48 ± 11) as compared to subjects with AF or other AT, p <  0.05. CONCLUSIONS: The evidence of elevated wedge pressure and the enlargement of the left atrium especially in patients with AF suggest a parallel involvement of the left atrial substrate in arrhythmia formation despite invasively confirmed evidence of purely isolated precapillary PH. Substantial differences were noticed between patients with type I AFL and the remaining patients with other arrhythmia types.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20023881
003      
CZ-PrNML
005      
20201214131540.0
007      
ta
008      
201125s2019 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s12872-019-1142-z $2 doi
035    __
$a (PubMed)31253083
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Fingrova, Zdenka $u 2nd Department of Medicine - Department of Cardiovascular Medicine, General University Hospital in Prague, U Nemocnice 2, 12808, Prague, Czech Republic. 2nd Department of Medicine - Department of Cardiovascular Medicine, 1st Faculty of Medicine, Charles University in Prague, U Nemocnice 2, 12808, Prague, Czech Republic.
245    14
$a The left atrial substrate plays a significant role in the development of complex atrial tachycardia in patients with precapillary pulmonary hypertension / $c Z. Fingrova, S. Havranek, D. Ambroz, P. Jansa, A. Linhart,
520    9_
$a BACKGROUND: Atrial fibrillation (AF) and related atrial tachyarrhythmias (AT), including type I atrial flutter (AFL) are frequently observed in patients with pulmonary hypertension (PH). Their relationship to hemodynamic changes, atrial size, and ventricular function are still not fully verified. METHODS: We retrospectively studied hemodynamic data, echocardiographic findings and arrhythmia incidence in 814 patients with invasively diagnosed precapillary PH (aged 59 ± 14 years; 46% males). Patients with combined or post-capillary PH were excluded. RESULTS: AF / AT were identified in 225 (28%) of all the study population. Compared to the subgroup without arrhythmia, patients with AF / AT had elevated right atrial pressure (11 ± 5 vs. 9 ± 5 mmHg), wedge pressure (11 ± 3 vs. 10 ± 3), a more enlarged right atrium (50 ± 12 vs. 47 ± 11 mm) and an increased left atrial diameter in the parasternal long axis projection, p <  0.05 for all comparisons. In the multivariate model, the left atrial size, patient age, arterial hypertension, diabetes and type of PH were associated with AF / AT occurrence, p <  0.05. Patients with type I AFL were more frequently male (39 (80%) vs. 62 (42%)), were younger (61 ± 11 vs. 67 ± 10 years), had increased pulmonary artery mean pressure (50 ± 12 vs. 45 ± 12 mmHg), less advanced left atrial dilatation (38 ± 10 vs. 42 ± 7 mm), and a more enlarged right atrium (56 ± 12 vs. 48 ± 11) as compared to subjects with AF or other AT, p <  0.05. CONCLUSIONS: The evidence of elevated wedge pressure and the enlargement of the left atrium especially in patients with AF suggest a parallel involvement of the left atrial substrate in arrhythmia formation despite invasively confirmed evidence of purely isolated precapillary PH. Substantial differences were noticed between patients with type I AFL and the remaining patients with other arrhythmia types.
650    _2
$a akční potenciály $7 D000200
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a fibrilace síní $x diagnóza $x epidemiologie $x patofyziologie $7 D001281
650    _2
$a flutter síní $x diagnóza $x epidemiologie $x patofyziologie $7 D001282
650    12
$a srdce - funkce levé síně $7 D016279
650    _2
$a ženské pohlaví $7 D005260
650    12
$a srdeční frekvence $7 D006339
650    _2
$a lidé $7 D006801
650    _2
$a plicní hypertenze $x diagnóza $x epidemiologie $x patofyziologie $7 D006976
650    _2
$a incidence $7 D015994
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a prevalence $7 D015995
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a hodnocení rizik $7 D018570
650    _2
$a rizikové faktory $7 D012307
650    _2
$a supraventrikulární tachykardie $x diagnóza $x epidemiologie $x patofyziologie $7 D013617
651    _2
$a Česká republika $x epidemiologie $7 D018153
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Havranek, Stepan $u 2nd Department of Medicine - Department of Cardiovascular Medicine, General University Hospital in Prague, U Nemocnice 2, 12808, Prague, Czech Republic. stepan.havranek@lf1.cuni.cz. 2nd Department of Medicine - Department of Cardiovascular Medicine, 1st Faculty of Medicine, Charles University in Prague, U Nemocnice 2, 12808, Prague, Czech Republic. stepan.havranek@lf1.cuni.cz.
700    1_
$a Ambroz, David $u 2nd Department of Medicine - Department of Cardiovascular Medicine, General University Hospital in Prague, U Nemocnice 2, 12808, Prague, Czech Republic. 2nd Department of Medicine - Department of Cardiovascular Medicine, 1st Faculty of Medicine, Charles University in Prague, U Nemocnice 2, 12808, Prague, Czech Republic.
700    1_
$a Jansa, Pavel $u 2nd Department of Medicine - Department of Cardiovascular Medicine, General University Hospital in Prague, U Nemocnice 2, 12808, Prague, Czech Republic. 2nd Department of Medicine - Department of Cardiovascular Medicine, 1st Faculty of Medicine, Charles University in Prague, U Nemocnice 2, 12808, Prague, Czech Republic.
700    1_
$a Linhart, Ales $u 2nd Department of Medicine - Department of Cardiovascular Medicine, General University Hospital in Prague, U Nemocnice 2, 12808, Prague, Czech Republic. 2nd Department of Medicine - Department of Cardiovascular Medicine, 1st Faculty of Medicine, Charles University in Prague, U Nemocnice 2, 12808, Prague, Czech Republic.
773    0_
$w MED00006809 $t BMC cardiovascular disorders $x 1471-2261 $g Roč. 19, č. 1 (2019), s. 157
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31253083 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201125 $b ABA008
991    __
$a 20201214131539 $b ABA008
999    __
$a ok $b bmc $g 1596200 $s 1114557
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 19 $c 1 $d 157 $e 20190628 $i 1471-2261 $m BMC cardiovascular disorders $n BMC Cardiovasc Disord $x MED00006809
LZP    __
$a Pubmed-20201125

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...